Join the club for FREE to access the whole archive and other member benefits.

Two new Ebola drugs report a 90% survival rate

Thanks to this cocktail of 3 antibodies, Ebola no longer means impending death


Key points from article :

A trial of two drugs showed significantly improved survival rates against Ebola.

More than 90% of infected people can survive if treated early with the most effective drug.

The drugs, REGN-EB3 and mAb114 attack the Ebola virus with antibodies.

WHO declared the Ebola crisis in Congo a "public health emergency of international concern".

The study was published in Lancet medical journal.

Mentioned in this article:

Click on resource name for more details.

Anthony S. Fauci

Director of the National Institute of Allergy and Infectious Diseases and Chief Medical Advisor to the President of United States

National Institute of Allergy and Infectious Diseases (NIAID)

Research to understand, treat, and prevent infectious, immunologic, and allergic diseases.

Sabue Mulangu

Senior Lecturer at Faculty of Medicine, University of Kinshasa

The Lancet

Medical journal covering general medicine

World Health Organization (WHO)

Specialized agency of the United Nations responsible for international public health

Topics mentioned on this page: